Our study focused on the transcription factor, RUNX1, which was found to be elevated in inflammatory conditions in human NASH [16], and hence, we preferred to use the MCD model as a NASH inflammatory model in our study. This evidence concerns the gene RUNX1 and metabolic dysfunction-associated steatohepatitis.